Results 191 to 200 of about 4,095,028 (342)

Targeting chemotherapy using oily contrast medium for malignant solid tumor. A brief review.

, 1984
Seiki Tashiro, Hiroshi Maeda
openalex   +2 more sources

Thyroid function in very low birthweight infants after intravenous administration of the iodinated contrast medium iopromide [PDF]

, 2000
J. Dembinski, Volker Arpe, Martin H. Kroll, G Hieronimi, Peter Bartmann   +4 more
openalex   +1 more source

Modeling hepatic fibrosis in TP53 knockout iPSC‐derived human liver organoids

Molecular Oncology, EarlyView.
This study developed iPSC‐derived human liver organoids with TP53 gene knockout to model human liver fibrosis. These organoids showed elevated myofibroblast activation, early disease markers, and advanced fibrotic hallmarks. The use of profibrotic differentiation medium further amplified the fibrotic signature seen in the organoids.
Mustafa Karabicici, Soheil Akbari, Ceyda Caliskan, Canan Celiker, Ozden Oz, Leman Binokay, Gökhan Karakulah, Serif Senturk, Esra Erdal   +8 more
wiley   +1 more source

Unilateral contrast-induced encephalopathy with contrast medium exudation: A case report. [PDF]

World J Clin Cases, 2023
Zhang ZY, Lv H, Wang PJ, Zhao DY, Zhang LY, Wang JY, Hao JH.   +6 more
europepmc   +1 more source

Femoral Vein Delivery of Contrast Medium Enhances Transthoracic Echocardiographic Detection of Patent Foramen Ovale

, 1994

openalex   +1 more source

Demonstration of a recto‐vaginal fistula with the ultrasound contrast medium Echovist [PDF]

, 2000
Wolfgang Henrich, J. Meckies, W. Friedmann   +2 more
openalex   +1 more source

PYCR1 inhibition in bone marrow stromal cells enhances bortezomib sensitivity in multiple myeloma cells by altering their metabolism

Molecular Oncology, EarlyView.
This study investigated how PYCR1 inhibition in bone marrow stromal cells (BMSCs) indirectly affects multiple myeloma (MM) cell metabolism and viability. Culturing MM cells in conditioned medium from PYCR1‐silenced BMSCs impaired oxidative phosphorylation and increased sensitivity to bortezomib.
Inge Oudaert, Lauren van den Broecke, Osman Aksoy, Judith Lind, Sonia Vallet, Arne Van der Vreken, Gamze Ates, Ann Massie, Ken Maes, Kim De Veirman, Elke De Bruyne, Karin Vanderkerken, Klaus Podar, Eline Menu   +13 more
wiley   +1 more source

Temporal trends of post-contrast acute kidney injury in patients with intravenous administration of iodinated contrast medium. [PDF]

Ren Fail, 2023
Wu X, Yan P, Duan SB, Luo XQ, Zhang NY, Deng YH.   +5 more
europepmc   +1 more source

Changes of blood hormone and electrolyte in nonionic contrast medium administration.Comparison of Iopamidol, Iohexol, and Ioxaglate.

, 1991
HISAO KUMAKURA
openalex   +2 more sources

In vitro properties of patient serum predict clinical outcome after high dose rate brachytherapy of hepatocellular carcinoma

Molecular Oncology, EarlyView.
Following high dose rate brachytherapy (HDR‐BT) for hepatocellular carcinoma (HCC), patients were classified as responders and nonresponders. Post‐therapy serum induced increased BrdU incorporation and Cyclin E expression of Huh7 and HepG2 cells in nonresponders, but decreased levels in responders.
Lukas Salvermoser, Jan Niklas Schäfer, Shraga Nahum Goldberg, Philipp Maximilian Kazmierczak, Moritz Nikolaus Gröper, Philipp Franz Linden, Elif Öcal, Tanja Burkard, Stefanie Corradini, Najib Ben Khaled, Moritz Wildgruber, Max Seidensticker, Jens Ricke, Matthias Stechele, Marianna Alunni‐Fabbroni   +14 more
wiley   +1 more source